Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04197999
Title A Study to Determine Safety and Tolerability of GMI-1359 in Subjects With HR+ Metastatic Breast Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors GlycoMimetics Incorporated
Indications

estrogen-receptor positive breast cancer

progesterone-receptor positive breast cancer

Therapies

GMI-1359

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.